ScholarIQanswers from OpenAlex & ORCID
David H. Johnson
ResearcherPublications, citations & collaboration network
David H. Johnson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David H. Johnson have?
ScholarIQindexed works
David H. Johnson has 312 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David H. Johnson have?
ScholarIQcitation count
David H. Johnson has 33,823 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David H. Johnson?
ScholarIQh-index
David H. Johnson has an h-index of 71 in OpenAlex.
What is the i10-index of David H. Johnson?
ScholarIQi10-index
David H. Johnson has an i10-index of 193 in OpenAlex.
What is the OpenAlex record for David H. Johnson?
ScholarIQopenalex
The OpenAlex for David H. Johnson is on the source record.
What are the most-cited papers on David H. Johnson?
ScholarIQmost cited works
TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer
Roy S. Herbst, Diane Prager, Róbert Hermann, L. Fehrenbacher, Bruce E. Johnson, Alan Sandler, Mark G. Kris, Hai T. Tran, Pam Klein, Xin Li, David A. Ramies, David H. Johnson, Vincent A. Miller
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
Kathy S. Albain, Ruth Swann, Valerie W. Rusch, Andrew T. Turrisi, Frances A. Shepherd, Colum J Smith, Yuhchyau Chen, Robert B. Livingston, Richard H. Feins, David R. Gandara, Willard A. Fry, Gail Darling, David H. Johnson, Mark R. Green, Robert C. Miller, Joanne Ley, W. Sause, James D. Cox
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
David G. Pfister, David H. Johnson, Christopher G. Azzoli, William T. Sause, Thomas J. Smith, Sherman Baker, Jemi Olak, Diane E. Stover, John R. Strawn, Andrew T. Turrisi, Mark R. Somerfield
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
Sarah Burdett, Jean‐Pierre Pignon, Jayne F. Tierney, Hélène Tribodet, Lesley Stewart, C. Le Péchoux, Anne Aupérin, Thierry Le Chevalier, Richard Stephens, R. Arriagada, Julian P. T. Higgins, David H. Johnson, Jan P. van Meerbeeck, Mahesh Parmar, Robert L. Souhami, Bengt Bergman, Jean-Yves Douillard, Ariane Dunant, Chiaki Endo, D.J. Girling, Harubumi Kato, Steven M. Keller, Hideki Kimura, Aija Knuuttila, Ken Kodama, Ritsuko Komaki, Mark G. Kris, Thomas E. Lad, Tommaso Claudio Mineo, Steven Piantadosi, Rafael Rosell, Giorgio V. Scagliotti, Lesley Seymour, Frances A. Shepherd, Richard Sylvester, Hirohito Tada, Fumihiro Tanaka, Valter Torri, David Waller, Ying Liang, for the Non-Small Cell Lung Cancer Collaborative Group